<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9783">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05690282</url>
  </required_header>
  <id_info>
    <org_study_id>210031</org_study_id>
    <nct_id>NCT05690282</nct_id>
  </id_info>
  <brief_title>Comparing Perioperative Outcomes in Pain Control</brief_title>
  <official_title>Randomized Controlled Trial Comparing Multimodal Pain Protocol Versus Hydrocodone-Acetaminophen for Post-Operative Pain Management in Orthopaedic Surgery Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project consists of a randomized controlled study design. Study candidates will include&#xD;
      all patients 18 years or older, who were evaluated at UCSD and found to have an orthopaedic&#xD;
      injury requiring surgery. Patients who consent to study participation will be randomized to&#xD;
      receive either the multimodal pain management protocol or standard oral&#xD;
      hydrocodone-acetaminophen for post-operative pain management. Data on opioid usage, pain&#xD;
      control, and functional status will be collected for each participant. After 3 years of data&#xD;
      collection, investigators will analyze this data to provide further insight in determining&#xD;
      appropriateness of pain regimens that reduce the overall opioid consumption. Given the&#xD;
      widespread opioid epidemic, it is imperative to develop alternative means to appropriately&#xD;
      manage pain in orthopaedic surgery patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 17, 2021</start_date>
  <completion_date type="Anticipated">May 17, 2026</completion_date>
  <primary_completion_date type="Anticipated">May 17, 2024</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Morphine equivalents used</measure>
    <time_frame>1 year</time_frame>
    <description>Morphine equivalents used over 1 year</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Score (0-10, 0=no pain, 10=most severe pain)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Complications</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Post-operative Pain</condition>
  <arm_group>
    <arm_group_label>Standard oral hydrocodone-acetaminophen post-op management</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Multimodal pain post-op management (Ibuprofen/Acetaminophen/GABAPentin/0.25%Bupivacaine)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Multimodal Pain Management (Ibuprofen/Acetaminophen/GABAPentin/0.25%Bupivacaine)</intervention_name>
    <description>Multimodal Pain Management to minimize patients' reliance on opioids.</description>
    <arm_group_label>Multimodal pain post-op management (Ibuprofen/Acetaminophen/GABAPentin/0.25%Bupivacaine)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Orthopaedic injury requiring surgery&#xD;
&#xD;
          -  Evaluation and treatment at UCSD&#xD;
&#xD;
          -  Age 18years or older&#xD;
&#xD;
          -  Ability to understand the content of the patient information/Informed Consent Form&#xD;
&#xD;
          -  Signed and dated Institutional Review Board (IRB) approved written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Polytrauma&#xD;
&#xD;
          -  Any not medically managed severe systemic disease&#xD;
&#xD;
          -  Their doctor has decided that it is in the patient's best interest to receive pain&#xD;
             management regimen of one type vs. the other.&#xD;
&#xD;
          -  The patient prefers one type of pain management protocol and is not willing to be&#xD;
             randomized.&#xD;
&#xD;
          -  Recent history of substance abuse (i.e. recreational drugs, alcohol) that would&#xD;
             preclude reliable assessment or confound pain control&#xD;
&#xD;
          -  Pregnancy or women planning to conceive within the subject participation period (1&#xD;
             year)&#xD;
&#xD;
             o Pregnancy will be self-reported and no test will be performed to test for it.&#xD;
&#xD;
          -  Prisoner&#xD;
&#xD;
          -  Participation in any other pharmacologic or medicinal product study within the&#xD;
             previous month that could influence the results of this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2023</verification_date>
  <study_first_submitted>December 19, 2022</study_first_submitted>
  <study_first_submitted_qc>January 9, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 19, 2023</study_first_posted>
  <last_update_submitted>May 5, 2023</last_update_submitted>
  <last_update_submitted_qc>May 5, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>William Kent</investigator_full_name>
    <investigator_title>Assistant Professor of Orthopaedic Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

